• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Fidelity National Financial, Inc. Announces Commencement of Consent Solicitation

    5/28/25 7:30:00 AM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers
    Finance
    Get the next $FG alert in real time by email

    JACKSONVILLE, Fla., May 28, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE:FNF) ("FNF" or the "Company") today announced the commencement of separate and distinct consent solicitations of the holders of each of its 4.500% Senior Notes due 2028 (the "2028 Notes"), 3.400% Senior Notes due 2030 (the "2030 Notes"), 2.450% Senior Notes due 2031 (the "2031 Notes") and 3.200% Senior Notes due 2051 (the "2051 Notes" and, collectively with the 2028 Notes, 2030 Notes and the 2031 Notes, the "Notes"; and each a "series of Notes") to effect a certain amendment to the indenture governing the Notes (the "Indenture") with respect to each series of Notes, as described below. As of May 27, 2025, there was $450,000,000 aggregate principal amount of 2028 Notes outstanding, $650,000,000 aggregate principal amount of the 2030 Notes outstanding, $600,000,000 aggregate principal amount of the 2031 Notes outstanding and $450,000,000 aggregate principal amount of the 2051 Notes outstanding.

    The proposed amendment to the Indenture would add a clause to the corporate existence covenant permitting the Company to redomesticate, by conversion, from a corporation organized under the laws of the State of Delaware to a corporation organized under the laws of the State of Nevada (the "Redomestication"). The Redomestication is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2025, as the same may be supplemented, modified or amended prior to the vote of the Company's shareholders contemplated thereby (the "Proxy Statement"). All other terms of the Indenture will remain unchanged. The Company believes that there are important reasons the Redomestication is in the best interest of the Company and its shareholders, which are discussed in the Consent Solicitation Statement (as defined below) and set forth in detail in the Proxy Statement. FNF does not believe there will be any change in FNF's business, properties, assets, liabilities, obligations or management because of the Redomestication, or that the Redomestication would impact FNF's reported revenues, income or cash flows.

    In April 2024, the Company solicited and received the consent of each series of Notes to make an amendment to the Indenture related to a redomestication proposal (the "2024 Consent Solicitations"); however, it did not receive the approval of its shareholders to consummate the Redomestication. Therefore, the Redomestication was abandoned prior to its consummation. As a result, no amendment to the Indenture became operative in 2024. Since the Board of Directors continues to believe there are many important reasons the Redomestication is advisable and in the best interests of the Company, the Company has decided to again seek approvals for the Redomestication.

    The Consent Solicitation is on the same terms in all respects (including as to the Consent Fee) as the 2024 Consent Solicitations.

    Each consent solicitation will expire at 5:00 p.m., New York City time, on June 3, 2025, unless extended or earlier terminated by the Company in its sole discretion (such date and time, as the same may be extended with respect to any series of notes, the applicable "Expiration Time"). Each of the consent solicitations is subject to the terms and conditions set forth in the consent solicitation statement, dated May 28, 2025 (the "Consent Solicitation Statement").

    The Company is offering to pay holders who validly deliver their consents at or prior to the applicable Expiration Time (and do not validly revoke such consents) a consent fee payable only immediately prior to consummation of the Redomestication of $1.00 in cash per $1,000 principal amount of Notes (the "Consent Fee"). No Consent Fee will be paid with respect to a series of Notes if the applicable Requisite Consents (as defined below) for such series of Notes are not received, if the applicable consent solicitation is terminated prior to the applicable Effective Time (as defined below) or if the Company abandons the Redomestication or if it is not completed for any reason whatsoever. The Company is not required to consummate the Redomestication even if it has received the Requisite Consent for any or all series of Notes and the approval of its shareholders to the Redomestication. If the Redomestication is abandoned prior to consummation or otherwise not completed for any reason whatsoever (including, without limitation, because the Company determines to effect a redomestication by way of merger or otherwise), or the conditions to these consent solicitations are not satisfied or waived, then no Consent Fee shall be payable.

    The Company has determined to proceed with the Redomestication by way of a conversion to a Nevada corporation. However, a redomestication from Delaware to Nevada can be achieved using other transaction structures, including by way of a merger with a Nevada corporation. The Company's Indenture would not prevent such a merger and, if any of the consent solicitations are not successful, the Company reserves the right in its sole discretion to consider effecting a redomestication by way of merger (or such other transaction structure as may be permitted by the Indenture) and not seek the consent of holders for any series of Notes pursuant to the consent solicitations. In that case, no Consent Fee would be paid with respect to any series of Notes if a redomestication is so effected, even if a supplemental indenture for such series of Notes has become effective.

    Holders of the Notes may revoke their consents at any time prior to the applicable Expiration Time or, if earlier, the Effective Time. The "Effective Time" means, for any series of Notes, the first time at which valid consents in respect of a majority in principal amount of the 2028 Notes, 2030 Notes, 2031 Notes and 2051 Notes, as applicable, have been received by the Company to approve the proposed amendment, and have not prior to such time been revoked. If adopted, non-consenting holders of Notes of each applicable series will be bound by the amendment to the Indenture but will not receive the Consent Fee.

    Approval of the proposed amendment for each series of Notes requires the consent of the holders of record as of 5:00 p.m., New York City time, on May 27, 2025, of, as applicable, the (i) 2028 Notes representing not less than a majority in aggregate principal amount of all 2028 Notes outstanding, (ii) 2030 Notes representing not less than a majority in aggregate principal amount of all 2030 Notes outstanding, (iii) 2031 Notes representing not less than a majority in aggregate principal amount of all 2031 Notes outstanding and (iv) 2051 Notes representing not less than a majority in aggregate principal amount of all 2051 Notes outstanding (collectively, the "Requisite Consents").

    If any of the Requisite Consents are received for one or more series of Notes, then a supplemental indenture with respect to each such series of Notes will be executed and the proposed amendment will become effective with respect to each such series of Notes for which the Requisite Consents were received, regardless of whether any other series of Notes received the consent of less than a majority in aggregate principal amount of such series by such time. However, the proposed amendment with respect to each series of Notes will not become operative with respect to such series of Notes until immediately prior to the consummation of the Redomestication and only if the applicable Consent Fee has been paid to DTC, as the registered holder of the Notes as of the Record Date, no later than the date on which the Redomestication is consummated, the conditions to the consent solicitations are satisfied and the Company accepts such consents. If the Redomestication is abandoned prior to consummation or otherwise not completed for any reason whatsoever (including, without limitation, because the Company determines to effect a redomestication by way of merger or otherwise), or the conditions to the consent solicitations are not satisfied or waived, then no Consent Fee shall be payable.

    For a complete statement of the terms and conditions of each consent solicitation, holders of each series of Notes should refer to the Consent Solicitation Statement. The Company may terminate, extend or amend any of the consent solicitations at any time. Each of the consent solicitations is an independent solicitation, is not conditional upon any of the other consent solicitations and can be modified, extended and/or terminated without affecting the terms or conditions of the other consent solicitations.

    The Solicitation Agent in connection with the consent solicitations is BofA Securities. Questions regarding the consent solicitations may be directed to BofA Securities, Attention: Liability Management Group at (888) 292-0070 (toll free) or (980) 387-3907 (collect). D.F. King & Co., Inc. is serving as Information Agent and Tabulation Agent in connection with the consent solicitations. Requests for assistance in delivering consents or for additional copies of the Consent Solicitation Statement should be directed to the Information Agent and Tabulation Agent at (866) 340-7108 (toll free) or (212) 269-5550 (banks and brokers) (collect) or by email at [email protected].

    This announcement is not an offer to purchase, a solicitation of an offer to purchase, or a solicitation of consents with respect to any securities, including the Notes. The consent solicitations are being made solely pursuant to the Consent Solicitation Statement and are subject to the terms and conditions stated therein. No recommendation is made, or has been authorized to be made, as to whether or not holders of the Notes should consent to the adoption of the proposed amendment. The Company reserves the right, in its sole discretion, to terminate or modify any of the consent solicitations.

    About Fidelity National Financial, Inc.

    Fidelity National Financial, Inc. (NYSE:FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries, and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority owned subsidiary F&G Annuities & Life, Inc. (NYSE:FG). FNF is the nation's largest title insurance company through its title insurance underwriters - Fidelity National Title, Chicago Title, Commonwealth Land Title, Alamo Title and National Title of New York - that collectively issue more title insurance policies than any other title company in the United States. More information about FNF can be found at www.fnf.com.

    Forward-Looking Statements and Risk Factors

    This press release contains forward-looking statements that involve a number of risks and uncertainties. Statements that are not historical facts, including statements regarding our expectations, hopes, intentions or strategies regarding the future are forward-looking statements. Forward-looking statements are based on management's beliefs, as well as assumptions made by, and information currently available to, management. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The risks and uncertainties which forward-looking statements are subject to include, but are not limited to: the potential impact of the consummation of the Redomestication on relationships, including with shareholders, bondholders and stakeholders; our ability to successfully realize the anticipated benefits of the Redomestication; the risk that we do not receive the Requisite Consents with respect to each series of Notes or shareholder approval for the Redomestication; adverse changes in general economic, business, political crisis, war and pandemic conditions, including ongoing geopolitical conflicts; consumer spending; government spending; the volatility and strength of the capital markets; investor and consumer confidence; foreign currency exchange rates; commodity prices; inflation levels; changes in trade policy; tariffs and trade sanctions on goods; trade wars; supply chain disruptions; weakness or adverse changes in the level of real estate activity, which may be caused by, among other things, high or increasing interest rates, a limited supply of mortgage funding or a weak U.S. economy; our potential inability to find suitable acquisition candidates; our dependence on distributions from our title insurance underwriters as a main source of cash flow; significant competition that F&G and our operating subsidiaries face; compliance with extensive government regulation of our operating subsidiaries, including regulation of title insurance and services and privacy and data protection laws; systems damage, failures, interruptions, cyberattacks and intrusions, or unauthorized data disclosures; and other risks detailed in the "Statement Regarding Forward-Looking Information," "Risk Factors" and other sections of FNF's Form 10-K and other filings with the Securities and Exchange Commission.

    FNF-G

    Cision View original content:https://www.prnewswire.com/news-releases/fidelity-national-financial-inc-announces-commencement-of-consent-solicitation-302466427.html

    SOURCE Fidelity National Financial, Inc.

    Get the next $FG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FG
    $FNF

    CompanyDatePrice TargetRatingAnalyst
    Fidelity National Financial Inc.
    $FNF
    4/8/2025$69.00Mkt Perform → Outperform
    Keefe Bruyette
    Fidelity National Financial Inc.
    $FNF
    1/3/2025Hold → Buy
    Deutsche Bank
    F&G Annuities & Life Inc.
    $FG
    9/5/2024$45.00Equal Weight
    Barclays
    Fidelity National Financial Inc.
    $FNF
    1/10/2024Hold
    Deutsche Bank
    F&G Annuities & Life Inc.
    $FG
    12/22/2023$48.00Neutral
    Piper Sandler
    Fidelity National Financial Inc.
    $FNF
    11/15/2023$44.00Equal Weight
    Barclays
    Fidelity National Financial Inc.
    $FNF
    10/2/2023$45.00 → $43.00Outperform → Mkt Perform
    Keefe Bruyette
    Fidelity National Financial Inc.
    $FNF
    7/18/2023$47.00Buy
    BTIG Research
    More analyst ratings

    $FG
    $FNF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fidelity National Financial Announces Quarterly Cash Dividend of $0.50

    JACKSONVILLE, Fla., Aug. 7, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE: FNF) ("FNF") today announced that its Board of Directors has declared a quarterly cash dividend of $0.50 per share of common stock. The dividend will be payable September 30, 2025, to stockholders of record as of September 16, 2025. About Fidelity National Financial, Inc. Fidelity National Financial, Inc. (NYSE:FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries, and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority owned subsidiary F&G Annuities & Life, Inc. (N

    8/7/25 7:30:00 AM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    F&G Annuities & Life Declares Dividends on Common and Preferred Stock

    DES MOINES, Iowa, Aug. 7, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE: FG) ("F&G") today announced that its Board of Directors has declared a quarterly cash dividend in the amount of $0.22 per common share. The dividend will be payable on September 30, 2025, to stockholders of record as of September 16, 2025. The Board also declared a quarterly cash dividend of $0.859375 per share of F&G's 6.875% Series A Mandatory Convertible Preferred Stock, to be paid on October 15, 2025, to holders of record as of October 1, 2025. About F&G F&G Annuities and Life, Inc. is committed to helping Americans turn their aspirations into reality. F&G is a leading provider of insurance solutions servin

    8/7/25 7:30:00 AM ET
    $FG
    Life Insurance
    Finance

    F&G Annuities & Life Announces Executive Management Transition

    ~ John Currier to Retire as President of F&G, Assumes Senior Advisory Role ~~ Conor Murphy to Assume a Broader Role as President and Chief Financial Officer ~ DES MOINES, Iowa, Aug. 6, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE:FG) (F&G or the Company) a leading provider of insurance solutions serving retail annuity and life customers and institutional clients, today announced that John Currier will transition from his role as President of F&G after 10 years of service with the Company in various leadership roles within the Retail Markets business and, effective August 7, 2025, Mr. Currier will assume a senior advisory role reporting to Chris Blunt, Chief Executive Officer. 

    8/6/25 4:30:00 PM ET
    $FG
    Life Insurance
    Finance

    $FG
    $FNF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shea Peter O Jr

    4 - Fidelity National Financial, Inc. (0001331875) (Issuer)

    7/2/25 11:42:38 AM ET
    $FNF
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Ammerman Douglas K

    4 - Fidelity National Financial, Inc. (0001331875) (Issuer)

    7/2/25 11:39:43 AM ET
    $FNF
    Specialty Insurers
    Finance

    Director Rood John D sold $539,552 worth of shares (10,000 units at $53.96), decreasing direct ownership by 4% to 230,569 units (SEC Form 4)

    4 - Fidelity National Financial, Inc. (0001331875) (Issuer)

    6/6/25 12:39:04 PM ET
    $FNF
    Specialty Insurers
    Finance

    $FG
    $FNF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Doka Celina J. Wang bought $432 worth of shares (10 units at $44.17), increasing direct ownership by 0.09% to 11,360 units (SEC Form 4)

    4 - F&G Annuities & Life, Inc. (0001934850) (Issuer)

    10/1/24 4:07:38 PM ET
    $FG
    Life Insurance
    Finance

    Blunt Christopher O bought $131,900 worth of shares (5,000 units at $26.38), increasing direct ownership by 1% to 434,695 units (SEC Form 4)

    4 - F&G Annuities & Life, Inc. (0001934850) (Issuer)

    10/4/23 6:34:02 PM ET
    $FG
    Life Insurance
    Finance

    $FG
    $FNF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fidelity National upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Fidelity National from Mkt Perform to Outperform and set a new price target of $69.00

    4/8/25 9:10:26 AM ET
    $FNF
    Specialty Insurers
    Finance

    Fidelity National upgraded by Deutsche Bank

    Deutsche Bank upgraded Fidelity National from Hold to Buy

    1/3/25 7:24:49 AM ET
    $FNF
    Specialty Insurers
    Finance

    Barclays initiated coverage on F&G Annuities & Life with a new price target

    Barclays initiated coverage of F&G Annuities & Life with a rating of Equal Weight and set a new price target of $45.00

    9/5/24 8:10:03 AM ET
    $FG
    Life Insurance
    Finance

    $FG
    $FNF
    SEC Filings

    View All

    SEC Form 13F-HR filed by Fidelity National Financial Inc.

    13F-HR - Fidelity National Financial, Inc. (0001331875) (Filer)

    8/12/25 4:07:28 PM ET
    $FNF
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by Fidelity National Financial Inc.

    10-Q - Fidelity National Financial, Inc. (0001331875) (Filer)

    8/7/25 4:52:11 PM ET
    $FNF
    Specialty Insurers
    Finance

    Fidelity National Financial Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Fidelity National Financial, Inc. (0001331875) (Filer)

    8/6/25 4:21:34 PM ET
    $FNF
    Specialty Insurers
    Finance

    $FG
    $FNF
    Leadership Updates

    Live Leadership Updates

    View All

    F&G Annuities & Life Announces Executive Management Transition

    ~ John Currier to Retire as President of F&G, Assumes Senior Advisory Role ~~ Conor Murphy to Assume a Broader Role as President and Chief Financial Officer ~ DES MOINES, Iowa, Aug. 6, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE:FG) (F&G or the Company) a leading provider of insurance solutions serving retail annuity and life customers and institutional clients, today announced that John Currier will transition from his role as President of F&G after 10 years of service with the Company in various leadership roles within the Retail Markets business and, effective August 7, 2025, Mr. Currier will assume a senior advisory role reporting to Chris Blunt, Chief Executive Officer. 

    8/6/25 4:30:00 PM ET
    $FG
    Life Insurance
    Finance

    Fidelity National Financial Appoints Gregg N. Sofer as Executive Vice President, Deputy Chief Legal Officer, and Chief Compliance Officer

    Succeeds Paul Perez, who retires after nearly two decades of distinguished service JACKSONVILLE, Fla., July 24, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE:FNF) (FNF or the Company), a leading provider of title insurance and transaction services to the real estate and mortgage industries and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority-owned, publicly traded subsidiary F&G Annuities & Life, Inc. (NYSE:FG) (F&G), today announced the appointment of Gregg N. Sofer as Executive Vice President, Deputy Chief Legal Officer, and Chief Compliance Officer. Mr. Sofer brings more than 30 years of lega

    7/24/25 4:15:00 PM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    IPX1031 Boosts New York Team with Attorney Ryan Vassar

    ARMONK, N.Y., May 6, 2025 /PRNewswire/ -- Investment Property Exchange Services, Inc. (IPX1031), the national leader in 1031 Qualified Intermediary services, is pleased to announce the appointment of Ryan Vassar, Esq. as Vice President, New Business Development for the state of New York. Ryan brings an impressive background in law and business, infusing fresh energy and innovative strategies into our operations in the state. A seasoned attorney, Ryan Vassar has a proven track record in business growth and strategic partnerships. His blend of legal expertise and business acumen

    5/6/25 10:03:00 AM ET
    $FNF
    Specialty Insurers
    Finance

    $FG
    $FNF
    Financials

    Live finance-specific insights

    View All

    Fidelity National Financial Announces Quarterly Cash Dividend of $0.50

    JACKSONVILLE, Fla., Aug. 7, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE: FNF) ("FNF") today announced that its Board of Directors has declared a quarterly cash dividend of $0.50 per share of common stock. The dividend will be payable September 30, 2025, to stockholders of record as of September 16, 2025. About Fidelity National Financial, Inc. Fidelity National Financial, Inc. (NYSE:FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries, and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority owned subsidiary F&G Annuities & Life, Inc. (N

    8/7/25 7:30:00 AM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    F&G Annuities & Life Declares Dividends on Common and Preferred Stock

    DES MOINES, Iowa, Aug. 7, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE: FG) ("F&G") today announced that its Board of Directors has declared a quarterly cash dividend in the amount of $0.22 per common share. The dividend will be payable on September 30, 2025, to stockholders of record as of September 16, 2025. The Board also declared a quarterly cash dividend of $0.859375 per share of F&G's 6.875% Series A Mandatory Convertible Preferred Stock, to be paid on October 15, 2025, to holders of record as of October 1, 2025. About F&G F&G Annuities and Life, Inc. is committed to helping Americans turn their aspirations into reality. F&G is a leading provider of insurance solutions servin

    8/7/25 7:30:00 AM ET
    $FG
    Life Insurance
    Finance

    FNF Reports Second Quarter 2025 Financial Results

    JACKSONVILLE, Fla., Aug. 6, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE:FNF) (FNF or the Company), a leading provider of title insurance and transaction services to the real estate and mortgage industries and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority-owned, publicly traded subsidiary F&G Annuities & Life, Inc. (NYSE:FG) (F&G), today reported financial results for the second quarter ended June 30, 2025. Net earnings attributable to common shareholders for the second quarter were $278 million, or $1.02 per diluted share (per share), compared to net earnings of $306 million, or $1.12 per s

    8/6/25 4:17:00 PM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    $FG
    $FNF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by FNF Group of Fidelity National Financial Inc.

    SC 13G - Fidelity National Financial, Inc. (0001331875) (Subject)

    2/14/24 4:00:13 PM ET
    $FNF
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by FNF Group of Fidelity National Financial Inc. (Amendment)

    SC 13G/A - Fidelity National Financial, Inc. (0001331875) (Subject)

    2/13/24 5:04:37 PM ET
    $FNF
    Specialty Insurers
    Finance

    SEC Form SC 13G filed by F&G Annuities & Life Inc.

    SC 13G - F&G Annuities & Life, Inc. (0001934850) (Subject)

    2/10/23 4:10:56 PM ET
    $FG
    Life Insurance
    Finance